Table 1.
Patient Demographics and Clinical Characteristics
| Characteristic | Cohort 1 (n = 33) | Cohort 2 (n = 18) | Total (n = 51) | |||
|---|---|---|---|---|---|---|
| No. of Patients | % | No. of Patients | % | No. of Patients | % | |
| Sex | ||||||
| Male | 20 | 60.6 | 14 | 77.8 | 34 | 66.7 |
| female | 13 | 39.4 | 4 | 22.2 | 17 | 33.3 |
| Age, years | ||||||
| Median | 57 | 57 | 57 | |||
| Range | 27-74 | 42-75 | 27-75 | |||
| KPS | ||||||
| 90-100 | 23 | 69.7 | 14 | 77.8 | 37 | 72.5 |
| 70-80 | 10 | 30.3 | 4 | 22.2 | 14 | 27.5 |
| Sites of metastatic disease | ||||||
| Liver | 12 | 36.4 | 6 | 33.3 | 18 | 35.3 |
| Lung | 1 | 3.0 | 4 | 22.2 | 5 | 9.8 |
| Lymph nodes | 33 | 100 | 17 | 94.4 | 50 | 98.0 |
| Peritoneum | 6 | 18.2 | 3 | 16.7 | 9 | 17.6 |
| Others* | 8 | 24.2 | 4 | 22.2 | 12 | 23.5 |
| Histological differentiation# | ||||||
| Poor | 25 | 75.8 | 11 | 61.1 | 36 | 70.6 |
| Good | 8 | 24.2 | 7 | 38.9 | 15 | 29.4 |
NOTE: *Including ovary, adrenal glands, subcutaneous of abdominal wall, pelvic cavity, bone and thoracic cavity. #Poor, including poorly differentiated adenocarcinoma, signet ring cell carcinoma and mucinous adenocarcinoma; Good, including moderate-well differentiated adenocarcinoma. KPS, Kamofsky performance status.